date,title,source
Nov-01-18,Nabriva files new drug application with FDA for urinary tract infection drug,American City Business Journals
Nov-01-18,Nabriva Therapeutics Completes Submission of New Drug Application to U.S. Food and Drug Administration for Intravenous CONTEPO to Treat Complicated Urinary Tract Infections,GlobeNewswire
Nov-06-18,Nabriva Therapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights,GlobeNewswire
Nov-20-18,Nabriva Therapeutics to Present at the 30th Annual Piper Jaffray Healthcare Conference,GlobeNewswire
Dec-20-18,Nabriva files 2 NDAs seeking approval for experimental pneumonia treatment,American City Business Journals
Dec-20-18,Nabriva Therapeutics Submits New Drug Applications to U.S. Food and Drug Administration for Intravenous and Oral Lefamulin to Treat Community-Acquired Bacterial Pneumonia in Adults,GlobeNewswire
Dec-21-18,Nabriva Therapeutics Announces Closing of up to a $75 million Term Loan,GlobeNewswire
Jan-04-19,Nabriva Therapeutics Announces Acceptance of the New Drug Application for Intravenous CONTEPO to Treat Complicated Urinary Tract Infections by FDA,GlobeNewswire
Jan-14-19,Nabriva Therapeutics Provides Update on PDUFA Date for Intravenous CONTEPO,GlobeNewswire
Jan-15-19,Nabriva Therapeutics (NBRV) Jumps: Stock Rises 6.7%,Zacks
Jan-15-19,"Nabriva Therapeutics Announces Webcast of Analyst & Investor Day on January 23, 2019",GlobeNewswire
Jan-17-19,Antimicrobials Working Group Announces Updates to Leadership Team,PR Newswire
Feb-19-19,Nabriva Therapeutics Announces Acceptance of New Drug Applications by the FDA for Intravenous and Oral Lefamulin to Treat Community-Acquired Bacterial Pneumonia in Adults,GlobeNewswire
Mar-12-19,Nabriva Therapeutics Reports 2018 Financial Results and Recent Corporate Highlights,GlobeNewswire
Apr-01-19,Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),GlobeNewswire
Apr-04-19,Nabriva Therapeutics (NBRV) in Focus: Stock Moves 7.5% Higher,Zacks
Apr-05-19,Do Options Traders Know Something About Nabriva Therapeutics (NBRV) Stock We Don't?,Zacks
Apr-11-19,Nabriva Therapeutics to Present Data at ECCMID Demonstrating Potential of Lefamulin for Patients with Community-acquired Bacterial Pneumonia (CABP) and CONTEPO (fosfomycin for injection) to Treat Complicated Urinary Tract Infections (cUTIs),GlobeNewswire
Apr-12-19,Antimicrobials Working Group Highlights Member Company Participation at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID),PR Newswire
Apr-29-19,Options Bulls Bet on This Drug Stock to Double,Schaeffer's Investment Research
Apr-29-19,FDA's decision looming on Nabriva's experimental antibiotic,American City Business Journals
Apr-30-19,FDA declines to approve Nabriva's antibiotic for urinary tract infections,Reuters
Apr-30-19,FDA declines to approve Nabriva's antibiotic for urinary tract infections,Reuters
Apr-30-19,Nabriva Therapeutics Receives Complete Response Letter from FDA on NDA for Intravenous CONTEPO (fosfomycin) for injection,GlobeNewswire
May-01-19,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nabriva Therapeutics plc - NBRV,CNW Group
May-01-19,Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),GlobeNewswire
May-01-19,"SHAREHOLDER ALERT: Investigation of Nabriva Announced by Holzer & Holzer, LLC",Business Wire
May-01-19,Nabriva Shares Tumble After FDA Issues CRL For Antibiotic Candidate,Benzinga
May-01-19,"The Daily Biotech Pulse: Nabriva Stumbles At FDA Hurdle, Gilead CFO To Retire, Eisai Ends Collaboration With Purdue",Benzinga
May-01-19,Nabriva fails to win FDA approval for experimental antibiotic,American City Business Journals
May-02-19,INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Nabriva Therapeutics plc Investors (NBRV),Business Wire
May-02-19,"Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Nabriva Therapeutics PLC (NBRV)",GlobeNewswire
May-02-19,Nabriva Investigated by Block & Leviton LLP For Violations of Federal Securities Laws,GlobeNewswire
May-02-19,"Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Nabriva Therapeutics PLC (NBRV)",ACCESSWIRE
May-03-19,Glancy Prongay & Murray LLP Announces Investigation on Behalf of Nabriva Therapeutics plc Investors,Business Wire
May-06-19,"NABRIVA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Nabriva Therapeutics plc To Contact The Firm",PR Newswire
May-07-19,"NABRIVA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Nabriva Therapeutics plc To Contact The Firm",GlobeNewswire
May-08-19,Nabriva Therapeutics to Present at the Bank of America Merrill Lynch 2019 Healthcare Conference,GlobeNewswire
May-08-19,How Many Nabriva Therapeutics plc (NASDAQ:NBRV) Shares Do Institutions Own?,Simply Wall St.
May-08-19,"After FDA rebuff, Nabriva turns its attention to Europe",American City Business Journals
May-08-19,Nabriva Therapeutics Announces Submission of Marketing Authorization Application for Lefamulin to Treat Community-Acquired Pneumonia in Adults by European Medicines Agency,GlobeNewswire
May-09-19,"Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Nabriva Therapeutics plc (NASDAQ: NBRV) and Encourages Nabriva Investors to Contact the Firm",GlobeNewswire
May-09-19,EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Nabriva Therapeutics plc  NBRV,Business Wire
May-09-19,"NABRIVA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Nabriva Therapeutics plc To Contact The Firm",ACCESSWIRE
May-10-19,"SHAREHOLDER INVESTIGATION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",ACCESSWIRE
May-10-19,"SHAREHOLDER ALERT - Nabriva Therapeutics PLC (NBRV) Bronstein, Gewirtz & Grossman, LLC Announces Class Action and Lead Plaintiff Deadline: July 8, 2019",GlobeNewswire
May-10-19,"NABRIVA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Nabriva Therapeutics plc To Contact The Firm",ACCESSWIRE
May-10-19,"IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",Business Wire
May-10-19,"SHAREHOLDER ALERT - Nabriva Therapeutics PLC (NBRV) Bronstein, Gewirtz & Grossman, LLC Announces Class Action and Lead Plaintiff Deadline: July 8, 2019",ACCESSWIRE
May-13-19,"Lifshitz & Miller LLP Announces Investigation of Glencore plc, Kingstone Companies, Inc., Mallinckrodt PLC, Metro Bank PLC, Momo Inc., Nabriva Therapeutics PLC, National General Holdings Corp, and Zillow Group, Inc.",PR Newswire
May-13-19,"IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",Business Wire
May-13-19,"LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Nabriva Therapeutics plc To Contact The Firm",GlobeNewswire
May-14-19,NABRIVA DEADLINE ALERT: Rosen Law Firm Reminds Nabriva Therapeutics plc Investors of Important Deadline in the Securities Class Action NBRV,Business Wire
May-14-19,NABRIVA THERAPEUTICS PLC ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Nabriva Therapeutics plc,GlobeNewswire
May-14-19,INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Nabriva Therapeutics plc Investors (NBRV),Business Wire
May-14-19,"ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",ACCESSWIRE
May-14-19,"LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Nabriva Therapeutics plc To Contact The Firm",ACCESSWIRE
May-14-19,"INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",GlobeNewswire
May-14-19,"Nabriva Therapeutics PLC (NBRV) Bronstein, Gewirtz & Grossman, LLC Announces Class Action and Lead Plaintiff Deadline: July 8, 2019",ACCESSWIRE
